Induction of B cell costimulatory function by recombinant murine CD40 ligand
β Scribed by Mary K. Kennedy; Kendall M. Mohler; Kurt D. Shanebeck; Peter R. Baum; Kathleen S. Picha; Carol A. Otten-Evans; Charles A. Janeway Jr.; Kenneth H. Grabstein
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 967 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
β¦ Synopsis
Induction of B cell costimulatory function by recombinant murine CD40 ligand
T cell-dependent regulation of B cell growth and differentiation involves an interaction between CD40, a Bcell surface molecule, and the CD40 ligand (CD4OL) which is expressed on activated CD4+ Tcells. In the current study, we show that recombinant membrane-bound murine CD40L induces B cells to express costimulatory function for the proliferation of CD4+ T cells. CD40L-or lipopolysaccharide (LPS)-activated, but not control-cultured B cells were strong costimulators of anti-CD3 or alloantigen-dependent T cell responses. The molecular interactions responsible for the increased costimulatory functions were examined by analyzing the activated B cells for changes in the expression of two costimulatory molecules, B7 and heat-stable antigen (HSA), as well as by the use of antagonists of B7 and HSA (CTLA4.Fc and 20C9, respectively). The expression of both B7 and HSA was enhanced on B cells activated with LPS. As observed in previous studies, the costimulatory activity of the LPS-activated B cells was dependent on both B7 and HSA and was completely inhibited in the presence of a combination of CTLA4.Fc and 20C9. In contrast, activation of B cells with CD40L induced the expression of B7 but did not enhance the expression of HSA. In addition the costimulatory activity of the CD40L-activated B cells was partially, but not completely, inhibited by the combination of CTLA4.Fc and 20C9. These results demonstrate that CD4OL regulates costimulatory function of B cells in part by inducing the expression of B7 and suggest that CD40L-activated B cells express an additional costimulatory activity that is not associated with LPS-activated B cells.
π SIMILAR VOLUMES
## Abstract ## Objective Autoreactive B cells play a key role in tissue injury in systemic autoimmune disease, and therefore a treatment resulting in B cell depletion could have benefit. This openβlabel study was undertaken to evaluate the efficacy of the antiβCD20 monoclonal antibody rituximab in
## Abstract We studied the ability of B lymphocytes from patients with Xβlinked hyper IgM syndrome (HIGM1) to be activated via the CD40 membrane receptor. HIGM1 is caused by a CD40 ligand gene mutation, leading to defective expression on the membrane of activated T lymphocytes. We found that trigge